These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2829498)

  • 21. Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu autoantibodies.
    Condom E; Vidal A; Rota R; Graus F; Dalmau J; Ferrer I
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):507-11. PubMed ID: 8291223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating antineuronal antibodies reach neurons in vivo: an autopsy study.
    Drlicek M; Liszka U; Jellinger K; Mohn-Staudner A; Lintner F; Grisold W
    J Neurol; 1992 Aug; 239(7):407-10. PubMed ID: 1328544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-neuronal antibodies in paraneoplastic neurological disorders with small-cell lung carcinoma.
    Moll JW; Henzen-Logmans SC; Vecht CJ
    Clin Neurol Neurosurg; 1990; 92(3):223-8. PubMed ID: 2171829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro.
    Greenlee JE; Parks TN; Jaeckle KA
    Neurology; 1993 Oct; 43(10):2049-54. PubMed ID: 8413965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of antibody in the central nervous system of a patient with paraneoplastic encephalomyeloneuritis.
    Brashear HR; Caccamo DV; Heck A; Keeney PM
    Neurology; 1991 Oct; 41(10):1583-7. PubMed ID: 1656326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoimmunity and paraneoplastic neurologic syndromes].
    Delattre JY; Davila L; Vega F; Poisson M
    Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies to neurons and to the cytoskeleton in small cell carcinoma with paraneoplastic sensory neuropathy.
    Alderuccio F; Rolland JM; Toner GC; Schwarz MA; McCluskey J; Toh BH
    Autoimmunity; 1989; 5(1-2):115-23. PubMed ID: 2562388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
    Lucchinetti CF; Kimmel DW; Lennon VA
    Neurology; 1998 Mar; 50(3):652-7. PubMed ID: 9521251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between human leukocyte antigens and the anti-Hu syndrome in patients with small-cell lung cancer.
    Uchuya M; Fleury A; Graus F; Costagliola D; Liblau R; Merle-Beral H; Théodorou I; Delattre JY
    Neurology; 1998 Feb; 50(2):565-6. PubMed ID: 9484403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system.
    Moll JW; Henzen-Logmans SC; Splinter TA; van der Burg ME; Vecht CJ
    J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):940-3. PubMed ID: 2178180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraneoplastic intestinal pseudo-obstruction, mononeuritis multiplex, and sensory neuropathy/neuronopathy.
    Simpson DA; Pawlak AM; Tegmeyer L; Doig C; Cox D
    J Am Osteopath Assoc; 1996 Feb; 96(2):125-8. PubMed ID: 8838909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraneoplastic painful ulnar neuropathy.
    Sharief MK; Robinson SF; Ingram DA; Geddes JF; Swash M
    Muscle Nerve; 1999 Jul; 22(7):952-5. PubMed ID: 10398219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis.
    Dalmau J; Furneaux HM; Gralla RJ; Kris MG; Posner JB
    Ann Neurol; 1990 May; 27(5):544-52. PubMed ID: 2163235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraneoplastic pseudo-obstruction, mononeuropathy multiplex, and sensory neuronopathy.
    Liang BC; Albers JW; Sima AA; Nostrant TT
    Muscle Nerve; 1994 Jan; 17(1):91-6. PubMed ID: 8264708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique.
    Knudsen A; Monstad SE; Dørum A; Lønning PE; Salvesen HB; Drivsholm L; Aarseth JH; Vedeler CA
    Cancer Immunol Immunother; 2006 Oct; 55(10):1280-4. PubMed ID: 16429314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics.
    Lee HR; Lennon VA; Camilleri M; Prather CM
    Am J Gastroenterol; 2001 Feb; 96(2):373-9. PubMed ID: 11232678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy.
    Budde-Steffen C; Anderson NE; Rosenblum MK; Posner JB
    Cancer Res; 1988 Jan; 48(2):430-4. PubMed ID: 2825975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients.
    Elrington GM; Murray NM; Spiro SG; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):764-7. PubMed ID: 1659614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology.
    Dalmau J; Gultekin HS; Posner JB
    Brain Pathol; 1999 Apr; 9(2):275-84. PubMed ID: 10219745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.